The bile acid TUDCA reduces age-related hyperinsulinemia in mice

Autor(es)

Zangerolamo, Lucas ; Carvalho, Marina ; Barssotti, Leticia ; Soares, Gabriela M. ; Marmentini, Carine ; Boschero, Antonio C. ; Barbosa, Helena Cristina L.

• Tipo de documento: Artigo Científico
• Fonte: SCIENTIFIC REPORTS; v. 12, n. 1, p. 16-pg., 2022-12-23.

Resumo

Aging is associated with glucose metabolism disturbances, such as insulin resistance and hyperinsulinemia, which contribute to the increased prevalence of type 2 diabetes (T2D) and its complications in the elderly population. In this sense, some bile acids have emerged as new therapeutic targets to treat TD2, as well as associated metabolic disorders. The taurine conjugated bile acid, tauroursodeoxycholic acid (TUDCA) improves glucose homeostasis in T2D, obesity, and Alzheimer's disease mice model. However, its effects in aged mice have not been explored yet. Here, we evaluated the actions of TUDCA upon glucose-insulin homeostasis in aged C57BL/6 male mice (18-month-old) treated with 300 mg/kg of TUDCA or its vehicle. TUDCA attenuated hyperinsulinemia and improved glucose homeostasis in aged mice, by enhancing liver insulin-degrading enzyme (IDE) expression and insulin clearance. Furthermore, the improvement in glucose-insulin homeostasis in these mice was accompanied by a reduction in adiposity, associated with adipocyte hypertrophy, and lipids accumulation in the liver. TUDCA-treated aged mice also displayed increased energy expenditure and metabolic flexibility, as well as a better cognitive ability. Taken together, our data highlight TUDCA as an interesting target for the attenuation of age-related hyperinsulinemia and its deleterious effects on metabolism. (AU)

• Processo FAPESP: 18/20213-2 - Papel do ácido biliar TUDCA no metabolismo glicêmico e energético de camundongos com Alzheimer e senis
• Beneficiário: Lucas Zangerolamo
• Modalidade de apoio: Bolsas no Brasil - Mestrado